Universitätsklinikum Schleswig-Holstein (UKSH)

Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry (2022) Stoelzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Journal article Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia (2022) Beelen DW, Arnold R, Stelljes M, Alakel N, Brecht A, Bug G, Bunjes D, et al. Journal article Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry (2022) Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schaefer-Eckart K, Steffen B, Sauer T, et al. Journal article Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment (2022) Harke NN, Wagner C, Hermann RM, Hadaschik BA, Radtke JP, Altay-Langguth A, Aufderklamm S, et al. Journal article Gestational diabetes mellitus and COVID-19: results from the COVID-19–Related Obstetric and Neonatal Outcome Study (CRONOS) (2022) Kleinwechter HJ, Weber KS, Mingers N, Ramsauer B, Schaefer-Graf UM, Groten T, Kuschel B, et al. Journal article Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysis (2022) Slagman A, Pigorsch M, Greiner F, Behringer W, Bernhard M, Bienzeisler J, Blaschke S, et al. Journal article Generalized pustular psoriasis: overview of the status quo and results of a panel discussion (2022) Reich K, Augustin M, Gerdes S, Ghoreschi K, Kokolakis G, Mößner R, Mrowietz U, et al. Journal article, Review article Impact of the COVID-19 Pandemic on Radiology in Inpatient and Outpatient Care in Germany: A Nationwide Survey Regarding the First and Second Wave. (2022) Bernatz S, Afat S, Othman AE, Nikolaou K, Sieren M, Saehn MJ, Dos Santos DP, et al. Journal article Real World Evidence on the comparative effectiveness of Ustekinumab vs anti-TNF in Crohn's disease with Propensity Score adjustment: maintenance phase results from the prospective observational RUN-CD study (2022) Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Deppe H, Mohl W, Teich N, Hoffstadt M, et al. Conference contribution Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naive patients with Crohn's Disease with Propensity Score adjustment: Maintenance phase results at week-52 from the prospective VEDOIBD study (2022) Di Giuseppe R, Plachta-Danielzik S, Bokemeyer B, Efken P, Mohl W, Hoffstadt M, Krause T, et al. Conference contribution